Non-albicans oral candidosis in HIV-positive patients

Journal of Antimicrobial Chemotherapy

Volumn 43, Issue 3, 1999, Pages 419-422

  Cartledge, J D ^a   Midgley, J ^a   Gazzard, B G ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; CD4 ANTIGEN; FLUCONAZOLE; PYRROLE;

ARTICLE; CANDIDIASIS; CULTURE MEDIUM; DRUG SENSITIVITY; FUNGUS CULTURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY;

EID: 0032991408     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/43.3.419     Document Type: Article

References (9)

1. Smith, D. G., Midgley, J., Allan, M., Connolly, G. M. & Gazzard, B. G. (1991). Itraconazole versus ketoconazole in the treatment of oral and oesophageal candidosis in patients infected with HIV. AIDS 5, 1367-71.
2. De Wit, S., Weerts, D., Goosens, H. & Clumeck, N. (1989). Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS. Lancet i, 746-7.
3. Dronda, F., Chaves, F., Alonso-Sanz, M., Laguna, F., Martinez-Suarez, J. V., Rodriguez-Tudela, J. L. et al. (1994). Clinical significance of mixed oropharyngeal candidiasis due to Candida albicans and non-albicans strains in HIV-infected patients. In Program and Abstracts of the Thirty-Fourth Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, FL, 1994. Abstract I215, p. 212. American Society for Microbiology, Washington, DC.
4. Odds, F. C. (1992). Antifungal susceptibility testing of Candida spp. by relative growth measurement at single concentrations of antifungal agents. Antimicrobial Agents and Chemotherapy 36, 1727-37.
5. Cartledge, J. D., Midgley, J. & Gazzard, B. G. (1996). Relative growth measurement of Candida species in a single concentration of fluconazole predicts the clinical response to fluconazole in HIV-infected patients with oral candidosis. Journal of Antimicrobial Chemotherapy 34, 275-83.
6. Cartledge, J. D., Midgley, J. & Gazzard, B. G. (1997). Itraconazole cyclodextrin solution: the role of in vitro susceptibility testing in predicting successful treatment of HIV-related fluconazole-resistant and fluconazole susceptible oral candidosis. AIDS 11, 163-8.
7. Cartledge, J. D., Midgley, J. & Gazzard, B. G. (1997). Clinical response to ketoconazole of HIV-related oral candidosis is predicted by Odds' relative growth method of susceptibility testing. Journal of Antimicrobial Chemotherapy 40, 117-9.
8. Wingard, J. R., Merz, W. G., Rinaldi, M. G., Johnson, T. R., Karp, J. E. & Saral, R. (1991). Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. New England Journal of Medicine 325, 1274-7.
9. Wingard, J. R., Merz, W. G., Rinaldi, M. G., Miller, C. B., Karp, J. E. & Saral, R. (1993). Association of Torulopsis glabrata infection with fluconazole prophylaxis in neutropenic bone marrow transplant patients. Antimicrobial Agents and Chemotherapy 37, 1847-9.